Trade Summary

9 months ago, Smith Scott Andrew, serving as CEO at Viatris Inc (VTRS), purchased 22,000 shares at $9.99 per share, for a total transaction value of $219,740.00. Following this transaction, Smith Scott Andrew now holds 314,807 shares of VTRS.

This purchase represents a 8.00% increase in Smith Scott Andrew's stake in the company. This is considered a high-conviction trade given the significant change in ownership.

The trade was executed on Tuesday, August 12, 2025 and publicly disclosed via SEC Form 4 filing on Wednesday, August 13, 2025 at 6:08 PM ET, 1 day after the trade was made.

Viatris Inc operates in the HEALTHCARE sector, specifically within the DRUG MANUFACTURERS - SPECIALTY & GENERIC industry. Insider buying activity in this sector can provide valuable signals about industry trends and company-specific developments.